These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16938803)

  • 21. Linkage of a candidate gene locus to familial combined hyperlipidemia: lecithin:cholesterol acyltransferase on 16q.
    Aouizerat BE; Allayee H; Cantor RM; Dallinga-Thie GM; Lanning CD; de Bruin TW; Lusis AJ; Rotter JI
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2730-6. PubMed ID: 10559018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. USF1 and dyslipidemias: converging evidence for a functional intronic variant.
    Naukkarinen J; Gentile M; Soro-Paavonen A; Saarela J; Koistinen HA; Pajukanta P; Taskinen MR; Peltonen L
    Hum Mol Genet; 2005 Sep; 14(17):2595-605. PubMed ID: 16076849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia.
    Geurts JM; Janssen RG; van Greevenbroek MM; van der Kallen CJ; Cantor RM; Bu X; Aouizerat BE; Allayee H; Rotter JI; de Bruin TW
    Hum Mol Genet; 2000 Sep; 9(14):2067-74. PubMed ID: 10958645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families.
    Pajukanta P; Porkka KV; Antikainen M; Taskinen MR; Perola M; Murtomäki-Repo S; Ehnholm S; Nuotio I; Suurinkeroinen L; Lahdenkari AT; Syvänen AC; Viikari JS; Ehnholm C; Peltonen L
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):841-50. PubMed ID: 9157946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fifty years studying hiperlipidemias: the case of familial combined hyperlipidemia].
    Aguilar-Salinas C; Gómez-Díaz R; Tusié-Luna MT
    Invest Clin; 2010 Jun; 51(2):145-58. PubMed ID: 20928976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels.
    Pajukanta P; Terwilliger JD; Perola M; Hiekkalinna T; Nuotio I; Ellonen P; Parkkonen M; Hartiala J; Ylitalo K; Pihlajamäki J; Porkka K; Laakso M; Viikari J; Ehnholm C; Taskinen MR; Peltonen L
    Am J Hum Genet; 1999 May; 64(5):1453-63. PubMed ID: 10205279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study.
    Coon H; Myers RH; Borecki IB; Arnett DK; Hunt SC; Province MA; Djousse L; Leppert MF
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2275-80. PubMed ID: 11031215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemia.
    Nanni L; Quagliarini F; Megiorni F; Montali A; Minicocci I; Campagna F; Pizzuti A; Arca M
    Atherosclerosis; 2010 Nov; 213(1):206-11. PubMed ID: 20832801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Confirmed locus on chromosome 11p and candidate loci on 6q and 8p for the triglyceride and cholesterol traits of combined hyperlipidemia.
    Naoumova RP; Bonney SA; Eichenbaum-Voline S; Patel HN; Jones B; Jones EL; Amey J; Colilla S; Neuwirth CK; Allotey R; Seed M; Betteridge DJ; Galton DJ; Cox NJ; Bell GI; Scott J; Shoulders CC
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2070-7. PubMed ID: 14500288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. USF1 contributes to high serum lipid levels in Dutch FCHL families and U.S. whites with coronary artery disease.
    Lee JC; Weissglas-Volkov D; Kyttälä M; Sinsheimer JS; Jokiaho A; de Bruin TW; Lusis AJ; Brennan ML; van Greevenbroek MM; van der Kallen CJ; Hazen SL; Pajukanta P
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2222-7. PubMed ID: 17673701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia.
    Hoffer MJ; Bredie SJ; Boomsma DI; Reymer PW; Kastelein JJ; de Knijff P; Demacker PN; Stalenhoef AF; Havekes LM; Frants RR
    Atherosclerosis; 1996 Jan; 119(2):159-67. PubMed ID: 8808493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common genetic variants contribute to primary hypertriglyceridemia without differences between familial combined hyperlipidemia and isolated hypertriglyceridemia.
    De Castro-Orós I; Cenarro A; Tejedor MT; Baila-Rueda L; Mateo-Gallego R; Lamiquiz-Moneo I; Pocoví M; Civeira F
    Circ Cardiovasc Genet; 2014 Dec; 7(6):814-21. PubMed ID: 25176936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping a gene for combined hyperlipidaemia in a mutant mouse strain.
    Castellani LW; Weinreb A; Bodnar J; Goto AM; Doolittle M; Mehrabian M; Demant P; Lusis AJ
    Nat Genet; 1998 Apr; 18(4):374-7. PubMed ID: 9537422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel variant in LPL gene is associated with familial combined hyperlipidemia.
    Taghizadeh E; Ghayour-Mobarhan M; Ferns GA; Pasdar A
    Biofactors; 2020 Jan; 46(1):94-99. PubMed ID: 31599081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia.
    Jarvik GP; Beaty TH; Gallagher PR; Coates PM; Cortner JA
    Genet Epidemiol; 1993; 10(4):257-70. PubMed ID: 8224806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?
    Brouwers MC; de Graaf J; van Greevenbroek MM; Georgieva AM; van der Kallen CJ; Ter Avest E; Stehouwer CD; Stalenhoef AF; de Bruin TW
    Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity.
    Deeb SS; Nevin DN; Iwasaki L; Brunzell JD
    Hum Mutat; 1996; 8(4):319-25. PubMed ID: 8956036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial-combined hyperlipidaemia in very young myocardial infarction survivors (< or =40 years of age).
    Wiesbauer F; Blessberger H; Azar D; Goliasch G; Wagner O; Gerhold L; Huber K; Widhalm K; Abdolvahab F; Sodeck G; Maurer G; Schillinger M
    Eur Heart J; 2009 May; 30(9):1073-9. PubMed ID: 19276196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia.
    Tahvanainen E; Pajukanta P; Porkka K; Nieminen S; Ikävalko L; Nuotio I; Taskinen MR; Peltonen L; Ehnholm C
    Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1810-7. PubMed ID: 9812922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia.
    Hoffer MJ; Snieder H; Bredie SJ; Demacker PN; Kastelein JJ; Frants RR; Stalenhoef AF
    Atherosclerosis; 2000 Aug; 151(2):443-50. PubMed ID: 10924721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.